ClinicalTrials.Veeva

Menu

Effect of Blue Light on Vagus Nerve Stimulation in Patients With Refractory Epilepsy (BLUELIGHTVNS)

C

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Status

Enrolling

Conditions

Refractory Epilepsy

Treatments

Other: electroencephalography, electrocardiogram, pupillometry, evoked potentials, light administration
Other: transcutaneous vagus nerve stimulation, electroencephalography, pupillometry, electrocardiogram, light administration

Study type

Interventional

Funder types

Other

Identifiers

NCT06304389
BLUELIGHT-VNS

Details and patient eligibility

About

Vagus nerve stimulation (VNS) is an adjunctive treatment for refractory epilepsy. Although widely used, there is still a substantial number of patients with insufficient response. Light, and particularly blue light, can stimulate alertness, attention and cognition through modulation of anatomical targets which are common to the vagal afferent network. This project aims at understanding how exposure to blue enriched light may influence VNS effects in patients with refractory epilepsy by exploring the modulation of a series of biomarkers of VNS action. This could possibly lead to new therapeutic strategies to increase efficacy of VNS.

Enrollment

34 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Patients:

VNS implanted since at least 3 months age >18-60 years; IQ >55 on Wechsler scale (normal status or mild cognitive impairment)

healthy participants aged between 18 and 35 years without any medical history (neurological / psychiatric disease)

Exclusion criteria

Patients:

other medical implanted devices than VNS, ocular diseases

Helthy participants:

medical implanted devices, cerebral trauma, ocular disease

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

34 participants in 2 patient groups

Patients with refractory epilepsy
Experimental group
Description:
Patients will not receive any drugs, but will participate to experiments involving electroencephalograpy, pupillometry and light administration.
Treatment:
Other: electroencephalography, electrocardiogram, pupillometry, evoked potentials, light administration
Healthy subjects
Experimental group
Description:
Subjects will not receive any drugs, but will participate to experiments involving electroencephalograpy, pupillometry and light administration.
Treatment:
Other: transcutaneous vagus nerve stimulation, electroencephalography, pupillometry, electrocardiogram, light administration

Trial contacts and locations

1

Loading...

Central trial contact

Inci cakiroglu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems